-
1
JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
Published 2022-01-01Subjects: “…JAK2…”
Get full text
Article -
2
-
3
Efficiency of interferon therapy in patients with essential thrombocythemia or polycythemia vera
Published 2016-12-01Subjects: Get full text
Article -
4
Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy
Published 2015-04-01Subjects: Get full text
Article -
5
JAK2-V617F Mutation Combined with Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia: a Case Report
Published 2011-06-01Subjects: Get full text
Article -
6
-
7
JAK2-V617F Mutation Combined with Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia: a Case Report
Published 2011-04-01Subjects: Get full text
Article -
8
Causal association between JAK2 and erectile dysfunction: a Mendelian randomization study
Published 2023-07-01Subjects: Get full text
Article -
9
Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
Published 2012-08-01Subjects: “…JAK2 inhibitor…”
Get full text
Article -
10
Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2V617F against myeloproliferative neoplasms
Published 2019-02-01Subjects: “…JAK2V617F…”
Get full text
Article -
11
Comprehensive Bioinformatics Analysis Combined with Wet-Lab Experiments to Find Target Proteins of Chinese Medicine Monomer
Published 2022-09-01Subjects: Get full text
Article -
12
Lung Clear “Sugar” Cell Tumor and Jak V617f Positive Essential Thrombocythemia: A simple Coıncıdence?
Published 2013-04-01Subjects: “…sugar cell, trombocytemia, jak2…”
Get full text
Article -
13
A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNs
Published 2021-03-01Subjects: “…jak2…”
Get full text
Article -
14
Polycythemia vera: Correlation of JAK2V617F mutation with clinicohematologic characteristics. A single centre experience.
Published 2014-08-01Subjects: Get full text
Article -
15
The role of JAK2 abnormalities in hematologic neoplasms.
Published 2009-07-01Subjects: “…JAK2…”
Get full text
Article -
16
Frequency of JAK2 and MPL Mutation in BCR/ABL Negative Myelofibrosis in KPK
Published 2022-06-01Subjects: “…JAK2, MPL, Myeloproliferative neoplasms.…”
Get full text
Article -
17
RARE CASE! SECOND PRIMARY MALIGNANCY IN LANGERHANS CELL HISTIOCYTOSIS, A JAK2+ CASE
Published 2024-12-01Subjects: Get full text
Article -
18
-
19
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerations
Published 2016-09-01Subjects: Get full text
Article -
20
Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
Published 2023-08-01Subjects: “…jak2v617f allele burden…”
Get full text
Article